SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000891293-11-000032
Filing Date
2011-04-08
Accepted
2011-04-08 21:26:45
Documents
1
Period of Report
2011-03-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4/A  
1 PRIMARY DOCUMENT primary_doc.xml 4/A 3940
  Complete submission text file 0000891293-11-000032.txt   5273
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062827100
CELL THERAPEUTICS INC (Issuer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
BIANCO JAMES A (Reporting) CIK: 0001198554 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-12465 | Film No.: 11750883